Today: 21 May 2026
Shopify stock drops again as ChatGPT checkout fees fuel fresh Wall Street split
4 February 2026
2 mins read

Shopify stock drops again as ChatGPT checkout fees fuel fresh Wall Street split

NEW YORK, Feb 4, 2026, 10:41 EST

  • Shopify shares dropped once more Wednesday morning, following a steep decline the previous day
  • Analysts remain divided on whether AI-powered “agentic commerce” will boost Shopify’s growth and profits
  • A Jefferies analyst highlighted the 4% merchant fee linked to Shopify’s ChatGPT checkout feature as a crucial swing factor

Shopify shares dropped again Wednesday, marking a second straight day of declines as investors digested conflicting analyst opinions on the Canadian e-commerce firm’s move into “agentic commerce” — AI agents that handle searching, selecting, and purchasing products for customers.

The selloff hits Shopify as it pushes its checkout and payments tools into emerging shopping channels, where buyers might skip merchant websites entirely. If AI assistants turn into the new storefronts, Shopify aims to remain the back-end engine that still takes a cut.

The narrative has bolstered Shopify’s valuation, yet it also sparks tough questions about margins, customer relationship control, and the pressure big platforms might put on fee collectors. As earnings approach, investors are fast to penalize any sign of “growth later, costs now.”

Shopify slipped roughly 4.7% to $113.65 in early trading, after closing Tuesday at $119.29. The stock’s decline on Tuesday outpaced the broader market, as growth and software shares took a hit.

Shopify dropped over 8% Tuesday afternoon despite analysts delivering a blend of upgrades and holds, all while highlighting the company’s potential in AI-powered shopping, TipRanks reported.

Jefferies analyst Samad Samana maintained a Hold rating on Shopify with a $160 price target, while Arete’s Rocco Strauss lifted his rating to Buy. Remember, a price target reflects where an analyst thinks a stock might head over time—not a guarantee.

Samana highlighted the 4% fee merchants face when using Shopify’s Instant Checkout on OpenAI’s ChatGPT, labeling Shopify an “agentic commerce beneficiary.” He flagged the fee as a potential hurdle for the channel’s profitability. He also mentioned Shopify’s connections with Alphabet, Google’s parent company, and Microsoft as possible avenues for expanding AI-driven shopping distribution.

“Beyond the economics, investors want clearer insight into the competitive risks after reports surfaced of Amazon’s investment in OpenAI,” Samana said, according to TipRanks. Strauss, in that same report, countered that concerns over AI coding tools eroding Shopify’s competitive moat overlook the “lock-in” effect from its merchant base.

TipRanks noted that Wolfe Research has just downgraded Shopify, citing worries over its valuation. The firm believes the stock already prices in much of the potential from agentic commerce. On Wall Street, Shopify carries a “Moderate Buy” consensus, according to TipRanks. That rating stems from 17 Buys and 10 Holds, with the average price target sitting at $179.56.

The stock kicked off 2026 slipping after a solid 2025. According to The Motley Fool, Shopify has dropped around 16% year-to-date and is trading at roughly 75.7 times forward earnings — a ratio that pits the share price against projected profits — compared to a sector average of 26.3.

Shopify’s core business is expanding rapidly. In its latest quarter, revenue jumped over 30%, while gross merchandise value (GMV)—the total sales volume processed on its platform—hit roughly $92 billion.

Yet the AI-shopping pitch isn’t without risk. Should merchants resist new fees, or if AI platforms funnel buyers to their own marketplaces, Shopify’s growth and take-rate forecasts might face swift headwinds. Rising competition could also push “agentic commerce” into a margin-crunched commodity.

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Intel stock slides after CEO flags new GPU push; investors eye Nvidia’s next readout
Previous Story

Intel stock slides after CEO flags new GPU push; investors eye Nvidia’s next readout

Apple stock jumps as Goldman flags App Store spending pickup, keeping AAPL in focus
Next Story

Apple stock jumps as Goldman flags App Store spending pickup, keeping AAPL in focus

Go toTop